Tesla has awarded its chief executive a “first step payment worth roughly $29 billion to replace a plan blocked by a Delaware ...

A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market ...

Wall Street looks to stabilise after last week’s tariff-driven slump, with investors gearing up for a crucial week packed ...

The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...

Major pharmaceutical companies facing patent cliffs and pipeline gaps may view Viking as an attractive acquisition target if clinical data proves successful. 10 stocks we like better than Viking ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success ...

Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ...

When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

Novo Nordisk downgraded to Buy amid guidance cuts & competition. Explore its long-term obesity drug potential, strong ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.